140 Acetylated ldl induces IL-1β release from human coronary endothelial cells by Almansouri, M. et al.
This is a repository copy of 140 Acetylated ldl induces IL-1β release from human coronary 
endothelial cells.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/142012/
Version: Accepted Version
Proceedings Paper:
Almansouri, M., Francis, S. and Chamberlain, J. (2018) 140 Acetylated ldl induces IL-1β 
release from human coronary endothelial cells. In: Heart. British Cardiovascular Society 
Annual Conference 'High Performing Teams', 04-06 Jun 2018, Manchester, UK. BMJ 
Publishing Group , A102-A103. 
https://doi.org/10.1136/heartjnl-2018-BCS.137
This article has been accepted for publication in Heart, 2018 following peer review, and the
Version of Record can be accessed online at 
http://dx.doi.org/10.1136/heartjnl-2018-BCS.137
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
10.1136/heartjnl-2018-BCS.137 
Heart 2018;104(suppl 6):A1-A118 
Acetylated LDL induces IL- ?ɴƌĞůĞĂƐĞĨƌŽŵHuman Coronary Endothelial Cells  
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Background: Atherosclerosis is a chronic vascular inflammatory disease characterised by 
disturbed arterial blood flow due to the atheromatous plaque build-up within arterial layers. 
Lipid rich plaques contain various forms of cholesterol, such as acetylated low density 
lipoprotein (AcLDL), that undergo many modification processes and which enter vascular 
cells, initiating over exuberant repair processes leading to arterial occlusion and life 
threatening myocardial infarction or stroke. Endothelial cells (EC) strongly drive the 
pathogenesis of atherosclerosis by producing pro-inflammatory cytokines, such as 
interleukin-1 beta (IL- ?ɴ ? ?We have recently shown that the release of IL- ?ɴĨƌŽŵŽĐĐƵƌƐ
via extracellular lysosomal derived vesicles, but the stimuli and mechanisms by which IL- ?ɴ
is released remain to be fully elucidated. We hypothesise that AcLDL enters the arterial 
endothelium and induces IL-1 secretion, potentially via a caspase-1/NLRP3 mechanism.  
Methods: Human coronary artery endothelial cells (HCAEC) isolated from three different 
donors were cultured and stimulated with pro-inflammatory cytokines dE&ɲĂŶĚ />- ?ɲ(10 
ng/ml each, for 48 hours), followed by incubation with native human AcLDL cholesterol at 
multiple concentrations (10-200 ug/ml) for 6 hours. Cell lysates and culture supernatants 
were collected and analysed for IL- ?ɴƵsing ELISA. Cell viability was also measured. 
Results: AcLDL induced the release of IL- ?ɴ ĨƌŽŵ ƐƚŝŵƵůĂƚĞĚHCAECs in a dose dependent 
manner with maximum release (155.4 pg/ml, n=3) at concentration of 50 ug/ml. This was 4 
fold greater than that released by cytokine-stimulated (38.49 pg/ml, n=3) and 3 fold greater 
than that released by neutrophil elastase (49.45 pg/ml, n=3). This release was not caused by 
toxicity of the AcLDL: cell viability was confirmed by lactate dehydrogenase cell viability 
assay.  
Conclusion: AcLDL is capable of eliciting IL- ?ɴƌĞůĞĂƐĞŝŶĂĐƚŝǀĂƚĞĚ,CAECs, without causing 
toxicity.  
